CLSI MM06, Revision A2, 2010: Quantitative Molecular Methods for Infectious Diseases; Approved Guideline, CLSI規格 MM06, 2010: 感染症のための定量的分子生物学的手法; 承認されたガイドライン

CLSI MM06, Revision A2, 2010(R2018): Quantitative Molecular Methods for Infectious Diseases; Approved Guideline (PDF/シングルユーザー)

産業規格・仕様書  >  CLSI 臨床・検査標準協会  > 




CLSI MM06, Revision A2, 2010(R2018): Quantitative Molecular Methods for Infectious Diseases; Approved Guideline (PDF/シングルユーザー)

35,530(税込)

数量

書名

CLSI MM06, Revision A2, 2010(R2018): Quantitative Molecular Methods for Infectious
Diseases; Approved Guideline
CLSI規格 MM06, 2010(R2018): 感染症のための定量的分子生物学的手法; 承認されたガイドライン
発行元 CLSI (Clinical and Laboratory Standards Institute)
発行年/月 2016年4月
装丁 PDF / シングルユーザー
ページ数 80 ページ
発送予定 1-2営業日以内にお送りします
※当ウェブ・ショップに掲載のない規格につきましては、別途お問合せ下さいませ。

 

Description

This guideline is to be used for implementation of tests for diagnostic purposes after the benefits and potential risks associated with the use of the test in clinical practice have been considered. Specimen handling and preparation; standards, calibrators, and reference materials; analytical and clinical verification/validation; reporting and interpreting results; and QC and clinical utility are the focus of this document. This document does not establish a clinically acceptable limit of quantification (LoQ) because consensus for most assays is currently lacking on this issue.

This document is intended for manufacturers or laboratories that develop tests, laboratories that perform or intend to implement such tests, clinicians that use the results to diagnose or manage patients, and agencies that regulate their use.